-
EP2599482
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2599482
| EP2599482 - Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.06.2014 Database last updated on 17.05.2024 | Most recent event Tooltip | 20.06.2014 | Application deemed to be withdrawn | published on 23.07.2014 [2014/30] | Applicant(s) | For all designated states Lunamed AG Rabengasse 4 7000 Chur / CH | [2013/23] | Inventor(s) | 01 /
Truog, Peter Rabengasse 4 7000 Chur / CH | 02 /
Buschmann, Helmut H. Sperberweg 15 52076 Aachen / DE | [2013/23] | Representative(s) | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | [N/P] |
| Former [2013/23] | Peters, Hajo, et al ZACCO GmbH Bayerstrasse 83 80335 München / DE | Application number, filing date | 11009476.0 | 30.11.2011 | [2013/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2599482 | Date: | 05.06.2013 | Language: | EN | [2013/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 28.02.2012 | Classification | IPC: | A61K31/192, A61K31/215, A61P25/28, A61P25/24, A61P25/00, A61P3/00, A61P9/00 | [2013/23] | CPC: |
A61K31/192 (EP);
A61K31/198 (EP);
A61K31/215 (EP);
A61K31/216 (EP);
A61K45/06 (EP);
A61P25/00 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P3/00 (EP);
A61P9/00 (EP)
(-)
| C-Set: |
A61K31/198, A61K2300/00 (EP);
A61K31/216, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/23] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | Therapeutische Verwendung von niedrig dosiertem Glyceryl Tri-(4-Phenylbutyrat) | [2013/23] | English: | Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) | [2013/23] | French: | Application thérapeutique à faible dose de triglycéryl-(4-phénylbutyrate) | [2013/23] | Examination procedure | 06.12.2013 | Application deemed to be withdrawn, date of legal effect [2014/30] | 13.01.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2014/30] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.11.2013 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2005053607 (MEDICIS PHARMACEUTICAL CORP [US]) [X] 1-5,8,10-13,15 * claims 1, 3, 7, 11, 17, 21 * * page 8, paragraph 36 *; | [I]EP1291015 (LUNAMED AG [CH]) [I] 1-15 * claims 1,4 * * columns 8,9; example 2 * * columns 1,2, paragraphs 4,5 *; | [A]WO2010025303 (HYPERION THERAPEUTICS [US], et al) [A] 1-15 * the whole document * | [X] - T. KASUMOV, "NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATS", DRUG METABOLISM AND DISPOSITION, (20040101), vol. 32, no. 1, doi:10.1124/dmd.32.1.10, ISSN 0090-9556, pages 10 - 19, XP055019599 [X] 1-4 * page 13, column l, paragraph 4 * DOI: http://dx.doi.org/10.1124/dmd.32.1.10 | [X] - CHANG ET AL, "Synthesis of triglycerides of phenylalkanoic acids by lipase-catalyzed esterification in a solvent-free system", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20061222), vol. 127, no. 4, doi:10.1016/J.JBIOTEC.2006.08.003, ISSN 0168-1656, pages 694 - 702, XP005810982 [X] 1-4 * page 697, column l, paragraph l * * page 701, column r * DOI: http://dx.doi.org/10.1016/j.jbiotec.2006.08.003 | [I] - LEE B ET AL, "Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 100, no. 3, doi:10.1016/J.YMGME.2010.03.014, ISSN 1096-7192, (20100701), pages 221 - 228, (20100605), XP027079433 [I] 1-15 * page 2, paragraphs 5,6 * * page 6 * DOI: http://dx.doi.org/10.1016/j.ymgme.2010.03.014 | by applicant | WO8504805 | DE19810383 | WO9307866 | WO9510271 | EP0725635 | WO9856370 | US6207195 |